Study period (months) | FEV1 change4-151(ml) | Treatment difference4-151 Budesonide-placebo (ml) | No. (%) of patients with ⩾15% in change in FEV1 | ||||
---|---|---|---|---|---|---|---|
Budesonide | Placebo | Budesonide | Placebo | ||||
0–3 | n = 38 | n = 34 | n = 38 | n = 34 | |||
−13 (−59 to 33) | −1 (−65 to 62) | −12 (−88 to 63) | 4 (11) | 7 (20) | |||
0–6 | n = 36 | n = 30 | n = 36 | n = 30 | |||
8 (−51 to 68) | 12 (−61 to 85) | −4 (−95 to 87) | 6 (17) | 8 (27) |